IGF-1 LR3
IGF-1 LR3 is a long-acting IGF-1 analogue explored in research involving IGF-1 receptor signalling and growth-factor pathways.
Research overview
IGF-1 LR3 is a modified analogue of insulin-like growth factor 1 designed for altered binding and extended biological activity in experimental systems. Research focuses on IGF-1 receptor signalling, growth and metabolic pathways.
Evidence status
IGF-1 biology is well established, but LR3 is chiefly a research analogue rather than a broadly established therapeutic compound. Findings from native IGF-1 should not automatically be assigned to LR3.
Areas under investigation
- IGF-1 receptor signalling
- Cell growth and differentiation pathways
- Metabolic signalling research
Explore the scientific literature
For primary-source reading, search the indexed biomedical literature and registered clinical studies. These links are provided as research gateways rather than endorsements of any particular finding.